Emphysema and air trapping mark faster decline in mild COPD

Design

Prospective community-based cohort, 3-year follow-up

Population

806 adults with mild to moderate COPD

Primary outcome

Exacerbations and FEV1 decline

Effect

Emphysema and air trapping linked to faster decline and more exacerbations

A prospective community cohort followed 806 people with mild to moderate COPD (FEV1/FVC below 0.70 and FEV1 at least 50% predicted) for three years, with CT assessment of emphysema, air trapping and airway changes.

Compared with people with preserved spirometry, they had more structural disease, more exacerbations and faster FEV1 decline. Phenotypes overlapped little. Emphysema and air trapping were associated with both faster FEV1 decline and more exacerbations. Symptoms and a recent exacerbation were associated with future exacerbations but not with faster decline.

Mild COPD is not one condition. In a patient with few symptoms, CT evidence of emphysema or air trapping may identify someone at risk of losing lung function, while a symptom-based view alone would miss them.

• Do not assume mild spirometric COPD is low risk; look for emphysema on any available CT.
• Prioritise smoking cessation and exposure reduction in patients with emphysema or air trapping.
• Use exacerbation history to predict future exacerbations, not lung function decline.
• Review spirometry over time in mild COPD rather than relying on a single result.

Why it matters

Symptom-based assessment of mild COPD misses the patients losing lung function fastest.

Don't overread it

This is an observational cohort from one country; it does not show that acting on CT findings changes outcomes.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.